- Financial Times•2 days ago
Drugs that selectively destroy cancer cells by destabilising their DNA will be developed in a £6m project funded by the Wellcome Trust at the University of Sussex, in collaboration with AstraZeneca. The ...
Pre-Market: 31.150.00 (0.00%) as of 4:13 AM EDT
|Bid||31.20 x 2400|
|Ask||31.23 x 2700|
|52wk Range||26.97 - 34.88|
|Day's Range||30.89 - 31.28|
|Avg Vol (3m)||5,053,811|
As of 4:02 PM EDT. Market closed.